订阅小程序
旧版功能

BIMEKIZUMAB IMPROVEMENTS IN EFFICACY ON DISEASE ACTIVITY ASSESSED VIA COMPOSITE ENDPOINTS IN BIOLOGIC DMARD-NAIVE AND TNFI-IR PATIENTS WITH ACTIVE PSA: POOLED 16-WEEK RESULTS FROM PHASE 3 RANDOMISED, PLACEBOCONTROLLED STUDIES

INTERNAL MEDICINE JOURNAL(2023)

引用 0|浏览23
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要